Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunohistochemical and genomic profiles of diffuse large B-cell lymphomas: implications for targeted EZH2 inhibitor therapy?
Dubois S, Mareschal S, Picquenot JM, Viailly PJ, Bohers E, Cornic M, Bertrand P, Veresezan EL, Ruminy P, Maingonnat C, Marchand V, Lanic H, Penther D, Bastard C, Tilly H, Jardin F. Dubois S, et al. Among authors: veresezan el. Oncotarget. 2015 Jun 30;6(18):16712-24. doi: 10.18632/oncotarget.3154. Oncotarget. 2015. PMID: 25762637 Free PMC article.
Non-invasive detection of somatic mutations using next-generation sequencing in primary central nervous system lymphoma.
Fontanilles M, Marguet F, Bohers É, Viailly PJ, Dubois S, Bertrand P, Camus V, Mareschal S, Ruminy P, Maingonnat C, Lepretre S, Veresezan EL, Derrey S, Tilly H, Picquenot JM, Laquerrière A, Jardin F. Fontanilles M, et al. Among authors: veresezan el. Oncotarget. 2017 Jul 18;8(29):48157-48168. doi: 10.18632/oncotarget.18325. Oncotarget. 2017. PMID: 28636991 Free PMC article.
Targeted genotyping of circulating tumor DNA for classical Hodgkin lymphoma monitoring: a prospective study.
Camus V, Viennot M, Lequesne J, Viailly PJ, Bohers E, Bessi L, Marcq B, Etancelin P, Dubois S, Picquenot JM, Veresezan EL, Cornic M, Burel L, Loret J, Becker S, Decazes P, Lenain P, Lepretre S, Lemasle E, Lanic H, Ménard AL, Contentin N, Tilly H, Stamatoullas A, Jardin F. Camus V, et al. Among authors: veresezan el. Haematologica. 2021 Jan 1;106(1):154-162. doi: 10.3324/haematol.2019.237719. Haematologica. 2021. PMID: 32079702 Free PMC article.
Successful treatment of T/myeloid mixed-phenotype acute leukemia with the translocation (10;11)(p13;q14) PICALM/AF10 with 3 + 7 myeloid standard treatment: A case report.
Krzisch D, Zduniak A, Veresezan EL, Daliphard S, Contentin N, Penther D, Etancelin P, Jardin F, Camus V. Krzisch D, et al. Among authors: veresezan el. Clin Case Rep. 2021 Jan 29;9(3):1507-1513. doi: 10.1002/ccr3.3815. eCollection 2021 Mar. Clin Case Rep. 2021. PMID: 33768878 Free PMC article.
Kidney Transplant T Cell-Mediated Rejection Occurring After Anti-CD19 CAR T-Cell Therapy for Refractory Aggressive Burkitt-like Lymphoma With 11q Aberration: A Case Report.
de Nattes T, Camus V, François A, Dallet G, Ferrand C, Guerrot D, Lemoine M, Morin F, Thieblemont C, Veresezan EL, Candon S, Latouche JB, Bertrand D. de Nattes T, et al. Among authors: veresezan el. Am J Kidney Dis. 2022 May;79(5):760-764. doi: 10.1053/j.ajkd.2021.07.012. Epub 2021 Aug 27. Am J Kidney Dis. 2022. PMID: 34461166
Complete hematologic response after belinostat treatment and allogeneic stem cell transplantation for multiple relapsed/refractory angioimmunoblastic T-cell lymphoma: A case report.
Camus V, Etancelin P, Drieux F, Veresezan EL, Picquenot JM, Penther D, Viennot M, Ruminy P, Contentin N, Lemasle E, Leprêtre S, Dubois S, Penichoux J, Stamatoullas A, Zduniak A, Lanic H, Jardin F. Camus V, et al. Among authors: veresezan el. Clin Case Rep. 2023 Jun 23;11(6):e7623. doi: 10.1002/ccr3.7623. eCollection 2023 Jun. Clin Case Rep. 2023. PMID: 37361652 Free PMC article.
High PDL1/PDL2 gene expression correlates with worse outcome in primary mediastinal large B-cell lymphoma.
Camus V, Viailly PJ, Drieux F, Veresezan EL, Sesques P, Haioun C, Durot E, Patey M, Rossi C, Martin L, Rainville V, Bohers E, Ruminy P, Penther D, Kaltenbach S, Bruneau J, Paillassa J, Tournilhac O, Willaume A, Antier C, Lazarovici J, Lévêque E, Decazes P, Becker S, Tonnelet D, Berriolo-Riedinger A, Gaulard P, Tilly H, Molina TJ, Traverse-Glehen A, Jardin F. Camus V, et al. Among authors: veresezan el. Blood Adv. 2023 Dec 12;7(23):7331-7345. doi: 10.1182/bloodadvances.2023011169. Blood Adv. 2023. PMID: 37862676 Free PMC article.